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Objective: To evaluate and compare the clinical outcomes and development of children born between
obstructive azoospermia (OA) couples and nonobstructive azoospermia couples (NOA) after testicular
sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI).
Materials and methods: Data were collected from infertile couples suffering from azoospermia who
underwent TESE and ICSI from January 2001 to December 2009 at Chang Gung Memorial Hospital,
Taiwan. A total of 154 ICSI cycles were performed using extracted testicular sperm from men with
obstructive azoospermia (67 ICSI cycles) and men with nonobstructive azoospermia (87 ICSI cycles).
Retrospective analysis of clinical outcomes and development of children born after TESE-ICSE between
obstructive azoospermia couples and nonobstructive azoospermia couples.
Results: The assisted reproductive technology (ART) result between OA and NOA groups, including age,
E2 level on hCG day, number of oocytes retrieved, normal fertilization rate, zygote Grade 1 score dis-
tribution, number of top-quality embryos transferred, clinical pregnancy rate per transfer, chemical
pregnancy rate per transfer, implantation rate, live birth rate per transfer, and abortion rate per transfer,
were all similar. Thirty-one live births resulted from 67 ICSE cycles in the OA group and 33 live births
from 87 ICSE cycles in the NOA group. The obstetric and perinatal outcomes were similar between the
groups, and children conceived by using ICSI were generally healthy without raised tendency of major
birth defect and development impairment.
Conclusion: In our study, there were no differences in the fertility rate and clinic pregnancy rate between
the OA and NOA groups using TESE-ICSI. Also, the clinical outcomes and development of children were
similar between the OA and the NOA groups using TESE-ICSI.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Azoospermia is uncommon but not rare, occurring in about 2%
of men in the general population and 10e20% of men treated at
infertility centers [1,2]. Azoospermia has different etiologies,and Gynecology, Kaohsiung
iversity College of Medicine,
iung city, Taiwan.
n).
bstetrics & Gynecology. Publishedpreviously described as pretesticular, testicular, and posttesticular;
although physiologically correct, this classiﬁcation is not always
practical for making decisions regarding treatment. Rather, the
classiﬁcation of azoospermia as obstructive (nondefective sper-
matogenesis) and nonobstructive (defective spermatogenesis) is
better for determining speciﬁc treatment options available to in-
dividual patients [3]. At present, even men without any sperm in
the ejaculate due to obstructions or problems in sperm production,
can father a biological child. Testicular sperm extraction (TESE)
remains the oldest and most informative diagnostic modality toby Elsevier Taiwan LLC. All rights reserved.
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azoospermia [4e8].
Recently, concerns have been raised about the quality and ge-
netic status of spermatozoa obtained from men with different eti-
ologies of male infertility, the impact of these spermatozoa on the
outcomes of assisted reproductive technology (ART), and the health
and well-being of offspring born to these men [9,10]. Intra-
cytoplasmic sperm injection (ICSI) has been shown to be effective in
the treatment of male infertility, suggesting that this techniquemay
overcome theproblems associatedwith the poorqualityand the low
quantity of spermatozoa [8,11]. The comparative success rates of ICSI
in OA andNOAmen is unclear, with several studies reporting similar
fertilization and pregnancy rates, whereas others found that ICSI
outcome rates were lower in NOA than in OA patients [12e14].
Since chromosome abnormalities may be associated with male
infertility, genetic factors have been assessed in OA and NOA men.
Prenatal examinations foundhigher rates of abnormal karyotypes in
children conceived fromNOA than fromOA sperm [9,14]. The rate of
aneuploidic sperm passed to offspring was higher in menwith NOA
than in thosewith OA [15e17], and an increase inmeiotic errorswas
found to be associated with poor testicular endocrine factor [18].
Moreover, the rate of anomalies in sex chromosomes was higher in
the sperm of men with NOA than with OA [19e21]. Less is known,
however, about the efﬁcacy of TESE-ICSE performed with sperma-
tozoa from men with OA and NOA, or about clinical outcomes and
the development of children born to these couples. We therefore
evaluated and compared the clinical outcomes and development of
children born to couples with OA and NOA undergoing TESE-ICSI.
Materials and methods
Patient population
Data were collected from azoospermic couples who underwent
ICSI and transcervical embryo transfer (ET) from January 2001 to
December 2009 at Chang Gung Memorial Hospital, Taiwan. Prior to
surgical extraction of testicular spermatozoa, an experienced
urologist performed a complete physical examination of the geni-
talia of all men with OA and NOA, including formal scrotal explo-
ration. Testicular spermatozoa were extracted by TESE from these
men with OA and NOA, frozen, thawed, and utilized in 67 and 87
ICSI cycles, respectively. These techniques have been described in
detail [8,22]. Endocrinology evaluation included assaying the con-
centrations of follicle stimulating hormone (FSH), luteinizing hor-
mone (LH), and testosterone. All testicular biopsy samples were
examined in our pathology department. A diagnosis of OA required
conﬁrmation of normal spermatogenesis by testicular biopsy. NOA
was pathologically categorized as due to spermatogenic hypoplasia,
maturation arrest, cryptorchidism, or testicular atrophy. We
excluded cases with abnormal karyotyping, e.g., Klinefelter syn-
drome (47, XXY). We also excluded cases of testis atrophy and bi-
opsies where no spermatozoa were obtained. Analysis of
chromosome aberrations were not performed routinely on our
male patients undergoing TESE.
All women included in this study had undergone a routine
infertility work-up. Informed consent for the ICSI-TESE procedures
were obtained from all study participants. The study protocol was
approved by the Ethics Committee and the Institutional Review
Board of Chang Gung Memorial Hospital.
Sperm retrieval, preparation, cryopreservation, and ICSI technique
The cryo-TESE procedure, including extraction of testicular tis-
sue, preparation of testicular sperm, and cryopreservation of
testicular spermatozoa, was performed as described [23,24].Almost 90% of the post-thawed spermatozoa showed at least oc-
casional tail twitching with normal morphology. The ICSI proce-
dure was performed as described, except that the sperm drop
preparation did not contain polyvinylpyrrolidone (PVP) [22,25e27].
Assessment of fertilization, embryo culture, and zygote and embryo
grading
Our standardized clinical methodology, including ovarian hy-
perstimulation following a standard downregulation regimen and
the performance of all procedures by a single team of embryolo-
gists, has been described previously [28,29]. Fertilization was
deﬁned as a zygote with two pronuclei (2PN). The oocytes were
cultured for 16e18 hours, after which they were assessed for the
presence of pronuclei and then scored according to the Z-score
scoring system [8,28].
Embryos were sequentially cultured in G1-2TM and G2-2TM
media (Scandinavian IVF Science). Blastomere number and regu-
larity were analyzed on Day 3. After culture for 2 days in G2-2TM
media, blastocyst formation was evaluated and scored based on
the state of blastocyst expansion, the consistency of the inner cell
mass, and the presence of trophectoderm cells.
“Top-quality” embryos were those that showed (1) Grade 1
embryo morphology on Day 3 (8 cells, blastomeres of equal size,
and no cytoplasmic fragments), and (2) blastocysts on Day 5 (full
blastocysts; inner cell mass with numerous tightly packed cells;
and trophectoderm with many cells forming a cohesive
epithelium).
Establishment and follow-up of pregnancy
Beginning on the day of oocyte retrieval, luteal-phase supple-
mentation with micronized progesterone (Utrogestan, 800 mg/day
intravaginally; Piette International Laboratories) was started.
Blastocysts, consisting of more than three 8-cell embryos, were
transferred on Day 5 and human chorionic gonadotropin (hCG;
500 IU/day) was routinely administered to all couples 6 days after
oocyte recovery. Chemical pregnancy was deﬁned as the presence
of hCG in urine 2 weeks after transfer, and clinical pregnancy was
deﬁned by the presence, on routine transvaginal ultrasonography
performed at 7 weeks of gestation on a gestational sac; if present,
patients were given micronized progesterone supplementation for
an additional 4 weeks.
Maternal, infant, and children outcome survey
The medical records of all live births from TESE-ICSI were
reviewed to assess maternal and infant outcomes and the devel-
opment of the latter. Obstetric events included preeclampsia,
eclampsia, gestational diabetes, preterm labor, and cesarean de-
livery. Adverse infant outcomes included low Apgar score, fetal
death, preterm delivery, major birth defects, fetal growth restric-
tion, intracranial hemorrhage, sepsis, and the need for mechanical
ventilation and intensive ICU care. Birth defects were grouped into
four categoriesdcongenital heart defects and gastrointestinal,
musculoskeletal, and chromosomal anomaliesdwith only those of
major morphologic importance or showing functional impairments
considered anomalies. Preterm birth was deﬁned as birth at a
gestational age <32 weeks, and fetal growth restriction (small-for-
gestational age) was deﬁned as a birth weight under the third
percentile in the corresponding standard population stratum. In-
trauterine death at gestational age >20 weeks or at birth weight
>500 g was deﬁned as fetal death. One and 7 minute Apgar scores
<5 and <7, respectively, were deﬁned as low.
Table 1
Comparison of intracytoplasmic sperm injection (ICSI) using testicular biopsy sperm
from men with obstructive azoospermia versus men with nonobstructive
azoospermia.
Transfer OA NON-OA p-value
No. of cycles 67 87
Age of female partner(y) 31.4 ± 5.3 32.3 ± 4.9 0.165
Age of male partner 34.7 ± 5.5 36.6 ± 6.6 0.112
Body mass index of Female
parter
22.4 ± 4.1 22.0 ± 2.8 0.983
Duration of infertility (y) 4.3 ± 3.2 3.4 ± 2.2 0.1143
Days of FSH treatment 9.4 ± 3.1 9.4 ± 2.1 0.347
Ampoules of 75 IU FSH 31.0 ± 13.2 34 ± 14.7 0.126
Endometrial thickness on
HCG day (cm)
l.4 ± 0.3 1.4 ± 0.3 0.736
E2 (pg/mL) on HCG day 2071.5 ± 1376.75 1816.6 ± 1315 0.205
No. of oocytes retrieved 7.6 ± 4.0 6.7 ± 4.2 0.119
No. of MII oocytes injected 427 505
Normal fertilization rate 90.4% (386/427) 92.1%.(465/505) 0.414
Zygote score
Z1 43.1% (184/427) 43.2% (218/505) 0.517
Z2 32.8% (140/427) 34.6 (176/505) 0.532
Z3 12.9% (55/427) 13.27 (67/505) 0.922
Z4 1.6% (7/427) 1.2% (6/505) 0.587
No of top-quality embryos
transferred
1.3 ± 1.04 1.05 ± 0.9 0.141
Clinical pregnancy rate per
transfer
47.l% (30/63) 45.6% (36/79) 0.866
Chemical pregnancy rate per
transfer
4.8% (3/63) 3.8% (3/79) 0.547
Implantation rate 27.2% (44/162) 20.2% (41/203) 0.135
Live birth rate per transfer 38.l% (24/63) 32.9% (26/79) 0.597
Abortion rate per transfer 4.8% (3/63) 6.3% (5/79) 0.491
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preschool developmental screening table developed for children in
Taiwan. The table design varies depending on the age of child, and
speciﬁc tables have been created for the ages 6, 9, 12, 18, 24, 30, 36,
42, 48, 54, and 60 months as shown in previous studies [8]. The
tables included detailed questions and was ﬁlled out by each child's
pediatrician. We assessed the following items: (1) child's feeding
and sleeping behavior, (2) posture, (3) coordination, (4) memory,
(5) problem-solving skills, (6) language skills, and (7) socialization
[8].
Statistical analysis
All statistical analyses were performed using SPSS 10.0 com-
puter software (SPSS, Inc.). Continuous data were reported as
mean ± SD. Mann-Whitney rank-sum tests were used to compare
means, and Fisher's exact tests were used to compare proportions.
All p values were two sided, with p < 0.05 considered statistically
signiﬁcant.
Results
The baseline characteristics of the OA and the NOA groups were
generally similar, including maternal age (31.4 ± 5.3 years vs.
32.3 ± 4.9 years), the age of their male partners (34.7 ± 5.5 years vs.
36.6 ± 6.6 years), and E2 concentration on hCG day
(2071.5 ± 1376.75 pg/mL vs. 1816.6 ± 1315 pg/mL). We also found
no differences in the mean numbers of oocytes retrieved (7.6 ± 4.0
vs. 6.7 ± 4.2), normal fertilization rate (90.4% vs. 92.1%), zygote
grade one score distribution (43.1% vs. 43.2%), and numbers of top-
quality embryos transferred (1.3 ± 1.04 vs. 1.05 ± 0.9). When we
assessed outcomes, we found that the two groups had similar
clinical pregnancy rates per transfer (47.1% vs. 45.6%), chemical
pregnancy rates per transfer (4.8% vs. 3.8%), implantation rates
(27.2% vs. 20.2%), and live birth rates (38.1% vs. 32.9%) and abortion
rates (4.8% vs. 6.3%) per transfer (Table 1).
We also analyzed perinatal outcomes and the subsequent
development of the children over a median of 10 years following
TESE-ICSE (Table 2). The 67 ICSI cycles in the OA group yielded 31
live births (46.3%), whereas the 87 ICSI cycles in the NOA group
yielded 33 live births (37.9%). The obstetric and perinatal outcomes
were comparable in these two groups. Moreover, the general health
of the children conceived using ICSI was satisfactory, with none
showing major retardation in psychomotor or intellectual
development.
Discussion
We found that the fertilization rates in our OA (90.4%) and NOA
(92.1%) groups were similar and that these rates were higher than
those previously reported for thesemethods, including inmenwith
sperm that were normal on FISH analysis [15]. There is, however,
concern that the quality of spermatozoa in terms of DNA damage or
maturation when collected from OA or NOA testicular semen. It is
also questioned whether testicular sperm of different etiology will
affect the outcome and safety of ICSI. Many studies have shown
conﬂicting results when ICSI is performed with testicular sperm.
Also, the relationship between OA or NOA sperm and the devel-
opment of embryos and clinical outcomes in patients undergoing
ICSI is still uncertain. Previous studies have shown differences in
ICSI outcomes using testicular sperm from men with OA and NOA.
For example, fertilization and pregnancy rates were found to be
signiﬁcantly lower using testicular sperm frommenwith NOA [14].
Another study also found that the fertilization ratewas signiﬁcantly
lower in NOA than in OA but found no signiﬁcant differences inpregnancy outcome [13]. Maternal age affected the implantation,
pregnancy, and delivery rates in both groups, suggesting an extra-
ovarian effect, not an effect of ovarian reserve [13]. These two
studies were limited by the differences in maternal and paternal
ages in the OA and NOA groups and the lack of information on
patient characteristics, including ovarian reserve and intrauterine
environment.
Fertilization and pregnancy rates were found to be similar when
freshmotile testicular spermwas taken frommenwith OA and NOA
[12]. Moreover, ongoing implantation and pregnancy rates were
lower using sperm from NOA than from OA patients [15]. Again,
however, the baseline characteristics of the two groups in these
studies were not comparable, because of factors such as female and
male ages, ovarian reserve, and intrauterine environment.
In contrast, we found that ICSI outcomes did not differ signiﬁ-
cantly between the OA and the NOA groups with similar baseline
characteristics. Zygote distribution, fertilization conditions, and
pregnancy outcomes were comparable, as were the number of top
quality embryos transferred. This result suggested that the key to
fertility in these couples may be the choice of high quality sper-
matozoa for ICSI based on morphology by a well-trained embry-
ologist. Owing to the limited number of spermatozoa retrieved and
injected per treatment cycle, choosing good quality sperm is always
the ﬁrst priority. It is reasonable that similar results were found in
ICSI regarding different testicular sperm.
In analyzing perinatal outcomes and the development of chil-
dren born to couples with OA and NOA who underwent TESE-ICSI,
we found no evidence of any differences, suggesting TESE-ICSI did
not have any negative effects on embryogenesis or fetal
development.
Other studies have assessed outcomes in children born through
ART and those conceived naturally. For example, ICSI children born
at term were found to develop normally, without any signiﬁcant
differences to naturally conceived children [30,31]. However, a
meta-analysis reported that the frequency of birth defects was
Table 2
Demographic characteristics of maternal and live birth: testicular sperm extraction-obstructive azoospermia (TESE-OA) cycles versus testicular sperm extraction-
nonobstructive azoospermia (TESE-NOA) cycles.
Transfer OA NON-OA p-value
No. of cycles 23 25
Age of female partner (y) 31. 3 ± 5.7 30.4 ± 4.9 0.556
Body mass index of female parter 22.9 ± 3.9 22.1 ± 2.7 0.454
Cesarean section, n (%) 14 (60.8%) 18 (72%) 0.543
Multiple pregnancy 8 (34.8%) 7 (28.0%) 0.757
High-order pregnancy with fetal reduction 3 (13.0%) 1 (4%) 0.338
Vanish twin 0 0
Pregnancy complications, n (%) 2/23 (8.7%) 2/25 (8%) 0.663
All deliveries 31 33
Female/male, n (%) 15 (48.4%)/16 (51.16%) 17 (51.5%)/16 (48.5%) 0.5
Parity: ﬁrst-born, n (%) 18 (78.3%) 23 (92%) 0.436
Birth, parameters
Gestational age (range), wk 36.8 ± 2.5 (30-40) 36.5 ± 3.8 (27-40) 0.746
Birth weight (range), g 3214 ± 3845.4 2652.9 ± 800.6 0.423
Prematurity,n (%) (gestational age <37 wk) 11 (35.5%) 12 (36.4%) 0.574
Birth weight <2500 g, n (%) 7/31 (22.6%) 13/33 (39.4%) 0.356
Apgar 1 min<5 or 5 min, <7, n (%) 1/31 (3.1%) 4/33 (12.1%) 0.183
Neonated respiratory distress syndrom, n (%) 5/31 (16.1%) 5/33 (15.2%) 0.592
Children's age at follow-up 7.5 ± 2.4 5.35 ± 2.7 0.01
(range) (1-10) (1-10)
Minor congenital anomalies
Heart 1 (3.2%) 1 (3.0%) 0.732
Musculoskeletal system 1 (3.2%) 0 0.484
Urogenital system 0 0
Major congenital anomalies
Heart (TOF) 0/31 1/33 (3.2%) 0.516
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births than those conceived naturally, whereas the rates were
comparable in those conceived by IVF and ICSI [32]. The develop-
ment of children conceived by ICSI with extracted testicular sperm
or ejaculated sperm from men with extreme severe oligoastheno-
teratozoospermia (OAT) was found to be similar [8]. It has been
found that genetic defects were more common in NOA than in OA
sperm, and the cryopreservation of TESE may have a negative
impact on sperm quality. However, the clinical outcomes and
development of children born after ICSI with frozen and thawed
testicular spermatozoa recovered from men with OA or NOA have
not been thoroughly assessed or compared.
Concerns have been raised about the risks of birth defects in
children born after ART [33]. An analysis of large numbers of chil-
dren found that malformation rates were comparable in naturally
conceived children and children conceived using ICSI [34]. We also
observed comparable obstetric and perinatal outcomes in children
conceived after ICSI with extracted testicular sperm or ejaculated
sperm from men with extreme severe OAT [8]. To our knowledge,
however, outcomes had not been compared to the children of men
with OA and NOA after TESE-ICSI. Moreover, the rates of aneuploid
(69.7%) and mosaic (31.2%) embryos of NOA patients were found to
be elevated [34], and the rates of chromosomally abnormal testic-
ular sperm were higher in men with NOA than with OA (42.1% vs.
6.3%), with embryos conceived from NOA sperm having lower
ongoing implantation and pregnancy rates than those conceived
from OA sperm, particularly those with abnormal FISH results [15].
Although these ﬁndings suggest that the general quality of testic-
ular sperm is poorer in NOA than in OA, we observed similar clinical
outcomes in the two groups, including embryogenesis, perinatal
outcomes and even childhood development. In our study, children
conceived using ICSI were healthy without any major psychomotor
or intellectual developmental retardation during the period of this
study.
In summary, we conclude that there is no evidence of differ-
ences in clinical outcomes and development of children after TESE-
ICSE between couples with obstructive and nonobstructive
azoospermia.Conﬂicts of interest
The authors have no conﬂicts of interest relevant to this article.
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